Optimi Health Statistics
Total Valuation
Optimi Health has a market cap or net worth of $28.36 million. The enterprise value is $22.60 million.
| Market Cap | 28.36M |
| Enterprise Value | 22.60M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Optimi Health has 4.30 million shares outstanding. The number of shares has increased by 10.19% in one year.
| Current Share Class | 5.73M |
| Shares Outstanding | 4.30M |
| Shares Change (YoY) | +10.19% |
| Shares Change (QoQ) | +33.44% |
| Owned by Insiders (%) | 16.94% |
| Owned by Institutions (%) | 7.75% |
| Float | 4.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 229.27 |
| Forward PS | 24.45 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 182.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.73 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4,174.32 |
Financial Efficiency
Return on equity (ROE) is -54.36% and return on invested capital (ROIC) is -18.73%.
| Return on Equity (ROE) | -54.36% |
| Return on Assets (ROA) | -15.64% |
| Return on Invested Capital (ROIC) | -18.73% |
| Return on Capital Employed (ROCE) | -28.15% |
| Weighted Average Cost of Capital (WACC) | 11.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.48% in the last 52 weeks. The beta is 1.60, so Optimi Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | +33.48% |
| 50-Day Moving Average | 4.68 |
| 200-Day Moving Average | 6.41 |
| Relative Strength Index (RSI) | 55.20 |
| Average Volume (20 Days) | 25,733 |
Short Selling Information
The latest short interest is 20,776, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 20,776 |
| Short Previous Month | 72,205 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 0.31 |
Income Statement
In the last 12 months, Optimi Health had revenue of $123,703 and -$4.86 million in losses. Loss per share was -$1.39.
| Revenue | 123,703 |
| Gross Profit | -95,962 |
| Operating Income | -3.52M |
| Pretax Income | -4.86M |
| Net Income | -4.86M |
| EBITDA | -2.84M |
| EBIT | -3.52M |
| Loss Per Share | -$1.39 |
Balance Sheet
The company has $9.21 million in cash and $3.62 million in debt, with a net cash position of $5.58 million or $1.30 per share.
| Cash & Cash Equivalents | 9.21M |
| Total Debt | 3.62M |
| Net Cash | 5.58M |
| Net Cash Per Share | $1.30 |
| Equity (Book Value) | 12.42M |
| Book Value Per Share | 2.89 |
| Working Capital | 4.14M |
Cash Flow
In the last 12 months, operating cash flow was -$3.78 million and capital expenditures -$79,628, giving a free cash flow of -$3.85 million.
| Operating Cash Flow | -3.78M |
| Capital Expenditures | -79,628 |
| Depreciation & Amortization | 702,690 |
| Net Borrowing | 1.74M |
| Free Cash Flow | -3.85M |
| FCF Per Share | -$0.90 |
Margins
| Gross Margin | -77.57% |
| Operating Margin | -2,848.05% |
| Pretax Margin | -3,928.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Optimi Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.19% |
| Shareholder Yield | -10.19% |
| Earnings Yield | -17.14% |
| FCF Yield | -13.59% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 72.97% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 20, 2026. It was a reverse split with a ratio of 1:30.
| Last Split Date | May 20, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |